- Home
- ETON vs CERT Comparison
ETON vs CERT Comparison
Compare ETON & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | CERT |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ETON | CERT |
|---|---|---|
| Price | $56.20 | $8.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $39.33 | $11.67 |
| AVG Volume (30 Days) | 428.6K | ★ 1.7M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 0.41 | N/A |
| Revenue | $79,950,000.00 | ★ $418,838,000.00 |
| Revenue This Year | $40.90 | $4.18 |
| Revenue Next Year | $47.23 | $5.39 |
| P/E Ratio | $136.12 | ★ N/A |
| Revenue Growth | ★ 104.94 | 8.75 |
| 52 Week Low | $14.27 | $4.45 |
| 52 Week High | $66.37 | $13.88 |
Technical Indicators
Market Signals| Indicator | ETON | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 49.17 | 54.45 |
| Support Level | $15.75 | $7.86 |
| Resistance Level | $66.37 | $8.39 |
| Average True Range (ATR) | 2.54 | 0.28 |
| MACD | -1.32 | -0.02 |
| Stochastic Oscillator | 18.40 | 75.00 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.